首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study.
【2h】

Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study.

机译:视网膜中央静脉阻塞中的全视网膜光凝:一项随机对照临床研究。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A randomised controlled study of photocoagulation compared with no treatment in central retinal vein occlusion is reported. Forty-eight patients were allocated into treated and control groups by a random procedure 3 months after their first visual symptoms. For the analysis they were subdivided into (1) ischaemic type, and (2) hyperpermeability-response macular-oedema type of central retinal vein occlusion. In neither group did treatment confer benefit as far as visual acuity was concerned. However, iris, disc, and retinal neovascularisation improved after treatment in the ischaemic group. In addition none of the treated patients progressed to neovascular glaucoma. Macular-oedema improved in treated patients with the hyperpermeability response, but the visual field was affected and atrophic changes at the macular precluded visual improvement. It is concluded that photocoagulation should be used only to prevent complications in the ischaemic type of central retinal vein occlusion. It does not appear to be of value in the hyperpermeability group.
机译:据报道,在视网膜中央静脉阻塞方面,光凝与未治疗相比有一项随机对照研究。在第一个视觉症状出现3个月后,通过随机程序将48位患者分为治疗组和对照组。为了进行分析,将它们分为(1)缺血型和(2)视网膜中央静脉阻塞的高通透反应黄斑水肿型。就视敏度而言,两组均未给予治疗益处。但是,缺血组的虹膜,椎间盘和视网膜新血管形成在治疗后有所改善。此外,所有接受治疗的患者均未进展为新血管性青光眼。经治疗的高通透性反应患者黄斑水肿得到改善,但视野受到影响,黄斑部萎缩性改变无法改善视力。结论是光凝只能用于预防缺血性视网膜中央静脉阻塞的并发症。它似乎在高通透性组中没有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号